Global Drug Discovery Informatics Market Outlook, Development Factors, Latest

0
7


Global Drug Discovery Informatics Market is expected to rise from its initial estimated value of USD 1.85 billion in 2018 to an estimated value of USD 4.34 billion by 2026, registering a CAGR of 11.27% in the forecast period of 2019-2026. Increasing investment on R&D is driving the growth of this market.

The market parameters of Drug Discovery Informatics report are of immense use to analyse market status, market share, growth rate, future trends, market drivers, opportunities, challenges, risks, entry barriers, sales channels, and distributors. Key data and information used while forming this report has been gathered from the consistent sources that range from journals, websites, research papers, case studies, and magazines. This market research report is a careful investigation of current scenario of the market and future estimations which deals with several market dynamics. Healthcare industry can achieve great benefits with Drug Discovery Informatics market research report which brings market and competitive landscape clearly into the focus and assist to make better decisions.

Get Sample Copy Of This Report + All Related Graphs @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-discovery-informatics-market

Few of the major competitors currently working in drug discovery informatics market are Jubilant Life Sciences Ltd., IBM Corporation, Infosys Limited, Thermo Fisher Scientific, PerkinElmer Inc., Schrödinger, LLC, Dassault Systèmes,  Charles River, Selvita, Certara, L.P.,  GVK Biosciences Private Limited, Collaborative Drug Discovery, Inc, OpenEye Scientific Software, IO Informatics, Inc., Albany Molecular Research Inc., Insilico Medicine, Charles River, Boehringer Ingelheim International GmbH.

Key Developments in the Market:

  • In November 2018, Accenture announced the launch of their open partner ecosystem whose main aim is to help the software vendors and life sciences companies so that they can do drug discovery. It will help the companies to improve their efficiency and productivity.   This will also give the access to the researchers to do genomics data analysis, biological data storage, biological registration etc.
  • In February 2018, Certara announced the launch of their new informatics platform version 10 of D360™. It is a visualize solution which will be used in cheminformatics and bioinformatics data sources which help the researcher to decide whether it is useful or not. This will help the researcher in quick decision making. It also has new presentation capability that will simply convert raw data into the sample view.

Access Complete Report @ https://www.databridgemarketresearch.com/reports/global-drug-discovery-informatics-market

Segmentation: `Global Drug Discovery Informatics Market

By Function

(Sequencing & Target Data Analysis, Docking, Molecular Modelling, Libraries & Database Preparation, Other Functions),

Solutions

(Software, Services),

End-…



Read More: Global Drug Discovery Informatics Market Outlook, Development Factors, Latest

Leave a reply